Article: Beyond the lab: trust, storytelling and the fight for America’s attention
In a World View article published in Nature Reviews Immunology, Science & Society Program Executive Director Aaron F. Mertz and Associate Professor at Icahn School of Medicine at Mount Sinai Shruti Naik explore the role of scientists in rebuilding public trust in science. Namely, by acting now to step out of the lab, embrace storytelling, and engage directly with communities, scientists can show the human side of discovery and make science more accessible, relevant, and trusted in everyday life.
Request for Proposals: Third Annual Renée Fleming Neuroarts Investigator Awards to Advance Arts and Health Research
NeuroArts Blueprint
The Renée Fleming Foundation in partnership with the NeuroArts Blueprint Initiative is offering year two of the Renée Fleming Neuroarts Investigator Awards. The Awards support innovative and collaborative research by early career researchers, designed to expand the evidence base of the emerging field of neuroarts and further the mission of the Neuroarts Blueprint Initiative. The mission of the NeuroArts Blueprint is to ensure the arts — and their use in all their many forms — become part of mainstream medicine and public health.
Press Release: NeuroArts Blueprint Initiative Launches Nationwide Network of Community Neuroarts Coalitions
NeuroArts Blueprint
On November 12, the NeuroArts Blueprint Initiative launched the Community Neuroarts Coalitions (CNC) Network to support 11 communities across the U.S. using the power of the arts to improve health and well-being. Each CNC will create evidence-to-impact collaborations among local partners to translate the science of neuroarts into practical programs that enhance the health, well-being, cohesion, and resilience of their communities.
News Article: Medicare Can’t Afford Not To Cover Ozempic
A decision for whether Medicare will cover a revolutionary new class of weight-loss treatments, which include drugs like Zepbound and Wegovy, could be imminent, according to Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services.
News Article: CMS Administrator Dr. Oz on GLP-1 for weight loss in Medicare: You’ll be hearing more soon
CMS Administrator Dr. Mehmet Oz addressed the rising discussion around covering GLP-1 medications (like Ozempic and Wegovy) for weight loss under Medicare. Citing “a lot of action” in the space, Oz confirmed that a decision on whether to expand coverage for these high-cost treatments is imminent. Read or watch the video to hear his full comments on the future of this policy.
News Article: Oz speaks out about shutdown, Medicaid cuts, Medicare Advantage audits and more
At Public Health Grand Rounds at the Aspen Institute on October 6, Dr. Mehmet Oz addressed the fallout of the government shutdown and stood by key Republican policy decisions. Learn his position on the expiring ACA subsidies, the future of Medicare Advantage audits despite a court setback, and his agency’s plan to implement controversial Medicaid work requirements. Click to read the six biggest policy revelations.
Photo by Katya Wanzer
